Published in
Wiley, Arthritis Care and Research, 5(74), p. 748-758, 2022
DOI: 10.1002/acr.24523
Links
Tools
One‐Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Journal article published in 2022 by
Bente Glintborg 
,
Ulf Lindström,
Daniela Di Giuseppe,
Daniela Di Giuseppe,
Sella Aarrestad Provan ,
Bjorn Gudbjornsson,
Merete Lund Hetland,
Brigitte Michelsen,
Johan K. Wallman,
Kalle Aaltonen,
Anna‐Mari Hokkanen,
Dan Nordström,
Tanja Schjødt Jørgensen,
Rebekka Lund Hansen,
Arni Jon Geirsson
and other authors.
,
Ulf Lindström,
Daniela Di Giuseppe,
Daniela Di Giuseppe,
Sella Aarrestad Provan ,
Bjorn Gudbjornsson,
Merete Lund Hetland,
Brigitte Michelsen,
Johan K. Wallman,
Kalle Aaltonen,
Anna‐Mari Hokkanen,
Dan Nordström,
Tanja Schjødt Jørgensen,
Rebekka Lund Hansen,
Arni Jon Geirsson
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 